University at Buffalo professor recognized for retina research
December 24th 2022Steven J. Fliesler, PhD, has been named the 2022 recipient of the Retina Research Foundation’s (RRF) Paul Kayser International Award in Retina Research presented by the International Society for Eye Research (ISER).
Read More
Collaboration focusing on boosting patient access, participation in ophthalmology clinical trials
December 20th 2022Parexel teams with MyEyeDr. to leverage MyEyeDr.’s 850+ offices across the United States to refer patients into ophthalmology and other therapeutic area clinical trials, expands Parexel’s Community Alliance Network to bring trials to patients where they are.
Read More
Researchers: Retinal cells may possess ability to protect themselves from diabetic retinopathy
December 16th 2022Investigators have found that cells within retinal blood vessels are endowed with a previously unappreciated ability to acquire resistance against the damaging effects of hyperglycemia in patients with diabetes mellitus.
Read More
Aviceda clears key IND toxicity hurdle with positive safety profile in non-human primates
December 8th 2022The results represent a major step towards first in-human clinical studies for this program - the first potential therapy for patients with geographic atrophy secondary to AMD that addresses the underlying causes of the disease.
Read More
Alcon finalizes deal to acquire Aerie Pharmaceuticals
November 22nd 2022According to the company, the deal adds pharmaceutical research and development capabilities and further expertise for future product pipeline. It also expands Alcon’s presence in the $20 billion global ophthalmic pharmaceutical category.
Read More
Belite Bio completes phase 3 clinical trial plans for LBS-008
November 18th 2022According to the company, LBS-008 is an orally administered tablet intended as an early intervention to slow disease progression in patients affected with Stargardt disease and dry age-related macular degeneration.
Read More
NeoLight rolls out ROP risk management software for pediatric ophthalmology
November 17th 2022According to the company, ROP Check builds upon its pediatric retina screening portfolio, adding digital management (schedule, document, bill, and transfer) for treating patients with retinopathy of prematurity.
Read More